UK markets closed

Centessa Pharmaceuticals plc (CNTA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.6200-0.2500 (-6.46%)
At close: 04:00PM EST
3.6200 0.00 (0.00%)
After hours: 04:00PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
Total revenue
-
0
0
Operating expenses
Research development
-
9,301
4,263
Selling general and administrative
-
1,139
790
Total operating expenses
-
10,440
5,053
Operating income or loss
-
-10,440
-5,053
Interest expense
-
378
118
Total other income/expenses net
-
155
105
Income before tax
-
-10,663
-5,061
Income from continuing operations
-
-10,663
-5,061
Net income
-
-10,663
-5,061
Net income available to common shareholders
-
-10,663
-5,061
Basic EPS
-
-0.15
-0.07
Diluted EPS
-
-0.15
-0.07
Basic average shares
-
70,891
70,891
Diluted average shares
-
70,891
70,891
EBITDA
-
-10,285
-4,937